Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and...
Prof Philippe Saiag - University of Versailles, Versailles, France
What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up? ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015
Anti-PD1 or tyrosine kinase inhibitors?
Dr Mark Middleton - University of Oxford, Oxford, UK
Anti-PD1 or tyrosine kinase inhibitors? ( Dr Mark Middleton - University of Oxford, Oxford, UK )
5 Nov 2015
New drugs and new trials in melanoma
Prof Jean-Jacques Grob - Marseille University, Marseille, France
New drugs and new trials in melanoma ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015
Highlights of EADO 2015
Prof Jean-Jacques Grob - Marseille University, Marseille, France
Highlights of EADO 2015 ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015
Disruptive technologies in cancer
Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Disruptive technologies in cancer ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015
Latest from the CoBRIM study
Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015
Anti-PD-1 or anti-CTLA-4 in first line therapy?
Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
5 Nov 2015
Long response and long responders in melanoma immunology
Prof Georgina Long - University of Sydney, Sydney, Australia
Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Nov 2015
What is the real role of UV in melanoma?
Dr Amaya Viros - The University of Manchester, Manchester, UK
What is the real role of UV in melanoma? ( Dr Amaya Viros - The University of Manchester, Manchester, UK )
5 Nov 2015
The Co-BRIM study: Quality-of-life assessment in patients with metastatic...
Prof Brigitte Dreno - Nantes University Hospital, Nantes, France
The Co-BRIM study: Quality-of-life assessment in patients with metastatic melanoma ( Prof Brigitte Dreno - Nantes University Hospital, Nantes, France )
5 Nov 2015
Benefit and risk analysis from the phase III OPTiM trial
Dr Kevin Harrington - Institute of Cancer Research, London, UK
Benefit and risk analysis from the phase III OPTiM trial ( Dr Kevin Harrington - Institute of Cancer Research, London, UK )
5 Nov 2015
Progress in targeted therapy of melanoma
Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA
Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )
5 Nov 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation